---
document_datetime: 2025-03-27 10:11:33
document_pages: 9
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/ontozry-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
document_name: ontozry-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
version: success
processing_time: 5.1631422
conversion_datetime: 2025-12-26 13:23:19.749176
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Ontozry

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                                             | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary                                                                                                                                                                                                                                                                                                       |
|----------------------|-------------------------------------------------------------------------------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| II/0029              | C.I.4 - Change(s) in the SPC, Labelling or PL due to new quality, preclinical, clinical or pharmacovigilance data | 27/02/2025                          |                                             | SmPC, Annex II and PL            | Update of SmPC Sections 4.2, 5.2, 6.6 to include the crushed tablets method of administration and instructions for administration through a nasogastric tube. Update of SmPC Section 4.5 to present the existing information on DDI in a tabular format. For more information, please refer to the Summary of |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

|           |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |            |     | Product Characteristics   |
|-----------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|---------------------------|
| IB/0033/G | This was an application for a group of variations. B.I.d.1.z - Stability of AS - Change in the re-test period/storage period or storage conditions - Other variation B.I.b.1.z - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Other variation B.I.b.1.z - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Other variation B.I.b.1.c - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Addition of a new specification parameter to the specification with its corresponding test method B.I.b.1.c - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Addition of a new specification parameter to the specification with its corresponding test method B.I.a.1.z - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Other variation A.4 - Administrative change - Change in the name and/or address of a manufacturer or an ASMF holder or supplier of the AS, starting material, reagent or intermediate used in the manufacture of the AS or manufacturer of a novel excipient | 20/02/2025 | n/a |                           |

<div style=\"page-break-after: always\"></div>

|         | and/or address of a manufacturer or an ASMF holder or supplier of the AS, starting material, reagent or intermediate used in the manufacture of the AS or manufacturer of a novel excipient A.4 - Administrative change - Change in the name and/or address of a manufacturer or an ASMF holder or supplier of the AS, starting material, reagent or intermediate used in the manufacture of the AS or manufacturer of a novel excipient A.4 - Administrative change - Change in the name and/or address of a manufacturer or an ASMF holder or supplier of the AS, starting material, reagent or intermediate used in the manufacture of the AS or manufacturer of a novel excipient A.4 - Administrative change - Change in the name and/or address of a manufacturer or an ASMF holder or supplier of the AS, starting material, reagent or intermediate used in the manufacture of the AS or manufacturer of a novel excipient   |            |     |                 |
|---------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|-----------------|
| IA/0032 | A.7 - Administrative change - Deletion of manufacturing sites                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        | 17/12/2024 |     | Annex II and PL |
| IB/0028 | B.I.d.1.a.4 - Stability of AS - Change in the re-test period/storage period - Extension or introduction of a re-test period/storage period supported by real time data                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               | 05/11/2024 | n/a |                 |
| N/0030  | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | 29/10/2024 | n/a |                 |

<div style=\"page-break-after: always\"></div>

| IA/0027             | B.III.2.a.2 - Change of specification(s) of a former non EU Pharmacopoeial substance to fully comply with the Ph. Eur. or with a national pharmacopoeia of a Member State - Excipient/AS starting material                                                                                                                                  | 30/09/2024   | n/a        |             |                                                                                                                                            |
|---------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|-------------|--------------------------------------------------------------------------------------------------------------------------------------------|
| IB/0026             | B.II.b.3.z - Change in the manufacturing process of the finished or intermediate product - Other variation                                                                                                                                                                                                                                  | 31/07/2024   | n/a        |             |                                                                                                                                            |
| IA/0025/G           | This was an application for a group of variations. B.II.c.2.a - Change in test procedure for an excipient - Minor changes to an approved test procedure B.II.c.1.c - Change in the specification parameters and/or limits of an excipient - Deletion of a non- significant specification parameter (e.g. deletion of an obsolete parameter) | 13/06/2024   | n/a        |             |                                                                                                                                            |
| IB/0024             | C.I.11.z - Introduction of, or change(s) to, the obligations and conditions of a marketing authorisation, including the RMP - Other variation                                                                                                                                                                                               | 19/04/2024   | n/a        |             |                                                                                                                                            |
| PSUSA/10921 /202309 | Periodic Safety Update EU Single assessment - cenobamate                                                                                                                                                                                                                                                                                    | 11/04/2024   | n/a        |             | PRAC Recommendation - maintenance                                                                                                          |
| PSUSA/10921 /202303 | Periodic Safety Update EU Single assessment - cenobamate                                                                                                                                                                                                                                                                                    | 09/11/2023   | 12/01/2024 | SmPC and PL | Refer to Scientific conclusions and grounds recommending the variation to terms of the Marketing Authorisation(s)' for PSUSA/10921/202303. |
| IA/0020/G           | This was an application for a group of variations. B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test                                                                                                                                                                                       | 27/11/2023   | n/a        |             |                                                                                                                                            |

<div style=\"page-break-after: always\"></div>

|                     | procedure B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure                                                                                                                                                   |            |            |      |                                   |
|---------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------|-----------------------------------|
| IB/0019             | B.II.b.3.z - Change in the manufacturing process of the finished or intermediate product - Other variation                                                                                                                                                               | 31/07/2023 | n/a        |      |                                   |
| IB/0018             | B.II.f.1.b.1 - Stability of FP - Extension of the shelf life of the finished product - As packaged for sale (supported by real time data)                                                                                                                                | 27/06/2023 | 05/10/2023 | SmPC |                                   |
| IB/0016/G           | This was an application for a group of variations. B.I.a.2.z - Changes in the manufacturing process of the AS - Other variation A.7 - Administrative change - Deletion of manufacturing sites                                                                            | 13/06/2023 | n/a        |      |                                   |
| PSUSA/10921 /202209 | Periodic Safety Update EU Single assessment - cenobamate                                                                                                                                                                                                                 | 14/04/2023 | n/a        |      | PRAC Recommendation - maintenance |
| IB/0015             | B.II.b.3.z - Change in the manufacturing process of the finished or intermediate product - Other variation                                                                                                                                                               | 17/02/2023 | n/a        |      |                                   |
| IB/0014/G           | This was an application for a group of variations. B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process of the AS B.I.a.3.a - Change in batch size (including batch size ranges) of AS or intermediate - Up to 10-fold | 17/02/2023 | n/a        |      |                                   |

<div style=\"page-break-after: always\"></div>

<!-- image -->

| increase compared to the size B.I.a.2.a - Changes in the the AS - Minor change of the AS B.I.a.3.a - Change in batch ranges) of AS or intermediate increase compared to the size B.I.a.3.a - Change in batch ranges) of AS or intermediate increase compared to the size B.I.a.1.f - Change in the starting material/reagent/intermediate Changes to quality control the AS -replacement or batch control/testing takes B.I.a.2.a - Changes in the the AS - Minor change of the AS B.I.a.2.a - Changes in the the AS - Minor change of the AS B.I.a.1.a - Change in the starting material/reagent/intermediate proposed manufacturer pharmaceutical group as manufacturer B.I.a.3.a - Change in batch ranges) of AS or intermediate   |
|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

<div style=\"page-break-after: always\"></div>

|                     | size B.I.a.3.a - Change in batch size (including batch size ranges) of AS or intermediate - Up to 10-fold increase compared to the originally approved batch size                                                                                                                                                                                                                                                               |            |            |      |                                   |
|---------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------|-----------------------------------|
| PSUSA/10921 /202203 | Periodic Safety Update EU Single assessment - cenobamate                                                                                                                                                                                                                                                                                                                                                                        | 27/10/2022 | n/a        |      | PRAC Recommendation - maintenance |
| IA/0012             | B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process of the AS                                                                                                                                                                                                                                                                                                                | 22/09/2022 | n/a        |      |                                   |
| IB/0011             | B.II.b.3.z - Change in the manufacturing process of the finished or intermediate product - Other variation                                                                                                                                                                                                                                                                                                                      | 26/07/2022 | n/a        |      |                                   |
| II/0009             | Update of section 5.3 of the SmPC in order to update information on toxicity to reproduction and development based on final results from nonclinical study 'Effects of Cenobamate (YKP3089) on Embryo- Fetal Development in Rats after Twice Daily Oral Administration'. The RMP version 3.0 has been agreed. C.I.4 - Change(s) in the SPC, Labelling or PL due to new quality, preclinical, clinical or pharmacovigilance data | 07/07/2022 | 05/10/2023 | SmPC |                                   |
| PSUSA/10921 /202109 | Periodic Safety Update EU Single assessment - cenobamate                                                                                                                                                                                                                                                                                                                                                                        | 05/05/2022 | n/a        |      | PRAC Recommendation - maintenance |

<div style=\"page-break-after: always\"></div>

| IAIN/0007/G   | a group of variations. A.5.b - Administrative change - Change in the name and/or address of a manufacturer/importer of the finished product, including quality control sites (excluding manufacturer for batch release) B.II.b.1.b - Replacement or addition of a manufacturing site for the FP - Primary packaging site B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place   | 27/01/2022   | n/a        |                     | This was an application for   |
|---------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|---------------------|-------------------------------|
| IB/0005/G     | This was an application for a group of variations. B.II.d.1.g - Change in the specification parameters and/or limits of the finished product - Addition or replacement (excluding biological or immunological product) of a specification parameter wit its corresponding test method as a result of a safety or quality issue B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure                                                           | 05/01/2022   | n/a        |                     |                               |
| IA/0006       | B.II.b.4.a - Change in the batch size (including batch size ranges) of the finished product - Up to 10-fold compared to the originally approved batch size                                                                                                                                                                                                                                                                                                                                            | 15/12/2021   | n/a        |                     |                               |
| T/0003        | Transfer of Marketing Authorisation                                                                                                                                                                                                                                                                                                                                                                                                                                                                   | 11/10/2021   | 28/10/2021 | SmPC, Labelling and |                               |

<div style=\"page-break-after: always\"></div>

|             |                                                                                                                                                                                                                                                                                                                                                                          |            |            | PL                     |                     |
|-------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|---------------------|
| IAIN/0002/G | This was an application for a group of variations. B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer responsible for importation and/or batch release - control/testing | 07/07/2021 | 28/10/2021 | Annex II and PL        | Not including batch |
| IAIN/0001   | A.1 - Administrative change - Change in the name and/or address of the MAH A.1 - Administrative change - Change in the name and/or address of the MAH                                                                                                                                                                                                                    | 12/05/2021 | 28/10/2021 | SmPC, Labelling and PL |                     |